Dopamine D3 Receptor Partial Agonists and Antagonists as Potential Drug Abuse Therapeutic Agents
- 21 April 2005
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (11) , 3663-3679
- https://doi.org/10.1021/jm040190e
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- Agents in Development for the Management of Cocaine AbuseDrugs, 2004
- Effects of a Dopamine D3 Receptor Ligand, BP 897, on Acquisition and Expression of Food-, Morphine-, and Cocaine-induced Conditioned Place Preference, and Food-seeking Behavior in RatsNeuropsychopharmacology, 2003
- Cocaine-Seeking Behavior in Response to Drug-Associated Stimuli in Rats: Involvement of D3 and D2 Dopamine ReceptorsNeuropsychopharmacology, 2003
- Social dominance in monkeys: dopamine D2 receptors and cocaine self-administrationNature Neuroscience, 2002
- Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the RatJournal of Medicinal Chemistry, 2000
- The effects of dopaminergic D₂ stimulation and blockade on smoking behavior.Experimental and Clinical Psychopharmacology, 1999
- Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration proceduresNeuropsychopharmacology, 1996
- Octreotide Effects on Orthostatic Hypotension in Patients with Multiple System AtrophyClinical Neuropharmacology, 1995
- Reinforcing drug seekingTrends in Pharmacological Sciences, 1992
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990